PubRank

Eric J Smart

Author PubWeight™ 43.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 2010 3.61
2 Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol 2003 2.15
3 Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids. Circ Res 2006 1.78
4 Crystallographic studies of human MitoNEET. J Biol Chem 2007 1.57
5 Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 2008 1.42
6 HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J Clin Invest 2003 1.39
7 Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci 2008 1.36
8 Retracted Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex. J Biol Chem 2001 1.34
9 Caveolae structure and function. J Cell Mol Med 2008 1.26
10 The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. Am J Physiol Heart Circ Physiol 2007 1.25
11 High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J Biol Chem 2002 1.20
12 HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 2003 1.15
13 Retracted Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction. J Biol Chem 2002 1.14
14 Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc Med 2005 1.10
15 Retracted Heterologous desensitization of EGF receptors and PDGF receptors by sequestration in caveolae. Am J Physiol Cell Physiol 2002 1.08
16 Retracted Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and an AMP kinase-dependent manner. J Biol Chem 2005 1.06
17 Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice. J Biol Chem 2008 1.04
18 A novel ligand-independent apoptotic pathway induced by scavenger receptor class B, type I and suppressed by endothelial nitric-oxide synthase and high density lipoprotein. J Biol Chem 2005 1.03
19 Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2009 1.02
20 Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 2009 1.01
21 Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord. FEBS J 2009 0.98
22 Increased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2007 0.97
23 Scavenger receptor BI prevents nitric oxide-induced cytotoxicity and endotoxin-induced death. Circ Res 2006 0.96
24 Retracted Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C. Am J Physiol Cell Physiol 2006 0.91
25 Caveolae: a regulatory platform for nutritional modulation of inflammatory diseases. J Nutr Biochem 2011 0.89
26 How HIV protease inhibitors promote atherosclerotic lesion formation. Curr Opin Lipidol 2007 0.87
27 Retracted Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin. Am J Physiol Cell Physiol 2007 0.87
28 Influence of salt on subcellular localization of nitric oxide synthase activity and expression in the renal inner medulla. Clin Exp Pharmacol Physiol 2007 0.86
29 Nitric oxide, caveolae, and vascular pathology. Cardiovasc Toxicol 2006 0.86
30 Voluntary wheel running ameliorates vascular smooth muscle hyper-contractility in type 2 diabetic db/db mice. Appl Physiol Nutr Metab 2007 0.86
31 Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J Nutr Biochem 2008 0.86
32 Cholesterol attenuates linoleic acid-induced endothelial cell activation. Metabolism 2003 0.83
33 Lipids: potential regulators of nitric oxide generation. Am J Physiol Endocrinol Metab 2004 0.83
34 Lipid rafts, caveolae and GPI-linked proteins. Adv Exp Med Biol 2012 0.82
35 Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors. J Biol Chem 2005 0.81
36 Gender as a regulator of atherosclerosis in murine models. Curr Drug Targets 2007 0.81
37 Glucagon-like peptide 1 and pancreatic polypeptide responses to feeding in normal weight and overweight children. J Pediatr Endocrinol Metab 2009 0.77
38 Caveolae, estrogen and nitric oxide. Trends Endocrinol Metab 2003 0.77
39 Estrogen in cardiovascular disease. Curr Opin Lipidol 2004 0.75